Related Experiment Videos
Flupirtine: the first Italian experience
G Ceccarelli1, M Ciampini, S Frontespezi
1Medical Department, Farmades S.p.A., Rome, Italy.
Postgraduate Medical Journal
|January 1, 1987
Summary
Flupirtine, a novel analgesic, demonstrated significant pain relief in clinical trials for post-operative, post-episiotomy, and sports injuries. It offered faster and more effective pain reduction compared to placebo and other analgesics with minimal side effects.
Area of Science:
- Pharmacology
- Clinical Trials
- Pain Management
Background:
- Flupirtine is a novel analgesic with a unique mechanism of action.
- Short-term, controlled clinical trials are essential for evaluating new analgesics.
Purpose of the Study:
- To assess the analgesic efficacy and safety of flupirtine in various pain conditions.
- To compare flupirtine's effectiveness against placebo and established analgesics like suprofen and paracetamol.
Main Methods:
- Five single-dose, short-term, controlled clinical trials involving 200 patients.
- Patients received flupirtine (100 mg single dose or 100 mg t.i.d.), suprofen (200 mg), paracetamol (500 mg), or placebo.
- Pain assessment used semi-quantitative scales and linear analogue scales.
Main Results:
- Flupirtine significantly reduced post-operative pain by 69% compared to 26% for placebo at 6 hours.
- Flupirtine demonstrated superior efficacy and faster onset of pain relief in post-episiotomy and sports injury pain compared to suprofen and paracetamol.
- Nausea was the only reported adverse reaction, occurring once during flupirtine treatment.
Conclusions:
- Flupirtine is an effective and well-tolerated analgesic for various acute pain conditions.
- The novel analgesic flupirtine shows promise as a valuable option for pain management.